Get the Stockscreener App
4.21
0.00%
0.00
Exicure Inc stock is traded at $4.21, with a volume of 9,423.
It is up +0.00% in the last 24 hours and up +0.96% over the past month.
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology.
See More
Previous Close:
$4.21
Open:
$4.25
24h Volume:
9,423
Relative Volume:
0.23
Market Cap:
$26.72M
Revenue:
$500.00K
Net Income/Loss:
$-7.88M
P/E Ratio:
-2.4852
EPS:
-1.694
Net Cash Flow:
$-5.49M
1W Performance:
-7.68%
1M Performance:
+0.96%
6M Performance:
-60.76%
1Y Performance:
+42.23%
1-Day Range:
$4.2201
$4.64
1-Week Range:
$4.1265
$4.73
52-Week Range:
$2.44
$36.00
Exicure Inc Stock (XCUR) Company Profile
Name
Exicure Inc
Sector
Industry
Phone
847-673-1707
Address
2430 N. HALSTED ST., CHICAGO, IL
Compare XCUR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
| 0.625 | 0 | 0 | 0 | 0 | 0.00 | |
MOBBW
Mobilicom Limited Warrants
|
2.50 | 4.21B | 0 | 0 | 0 | 0.00 |
|
GOODO
Gladstone Commercial Corporation
|
20.00 | 372.90M | 0 | 0 | 0 | 0.00 |
|
SHMD
Schmid Group N V
|
4.90 | 217.47M | 0 | 0 | 0 | 0.00 |
|
PSNYW
Polestar Automotive Holding Uk
|
0.227 | 502.27M | 2.07B | -1.42B | -1.37B | -0.6765 |
|
DAVEW
Dave Inc
|
1.3695 | 0 | 0 | 0 | 0 | 0.00 |
Exicure Inc Stock (XCUR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-13-21 | Downgrade | Chardan Capital Markets | Buy → Neutral |
| Dec-18-20 | Initiated | BMO Capital Markets | Outperform |
| Nov-20-19 | Initiated | Guggenheim | Buy |
Exicure Inc Stock (XCUR) Latest News
Will Exicure Inc. stock pay special dividendsMarket Volume Summary & Target Return Focused Stock Picks - newser.com
Combining machine learning predictions for Exicure Inc.July 2025 Levels & Risk Adjusted Swing Trade Ideas - newser.com
Can Exicure Inc. (2H0) stock test all time highsJuly 2025 Fed Impact & High Yield Equity Trading Tips - newser.com
Is Exicure Inc. stock supported by strong fundamentals2025 Market Trends & Community Consensus Stock Picks - newser.com
Trend analysis for Exicure Inc. this weekWeekly Investment Recap & Weekly Return Optimization Plans - newser.com
Will Exicure Inc. (2H0) stock hit analyst forecastsJuly 2025 Summary & Precise Swing Trade Entry Alerts - newser.com
Identifying reversal signals in Exicure Inc.Index Update & Weekly Breakout Stock Alerts - newser.com
How Exicure Inc. (2H0) stock correlates with oil marketsJuly 2025 Setups & Detailed Earnings Play Strategies - newser.com
How institutional ownership impacts Exicure Inc. stockJuly 2025 Retail & Consistent Profit Trade Alerts - newser.com
How analysts revise price targets for Exicure Inc. (2H0) stockMarket Sentiment Summary & AI Optimized Trading Strategy Guides - newser.com
New Burixafor Clinical Data to be Presented as an Oral Presentation at the 2025 ASH Annual Meeting - The Manila Times
Exicure (NASDAQ: XCUR) to present Phase 2 burixafor data at ASH; 18/19 to AHCT - Stock Titan
Live market analysis of Exicure Inc.Quarterly Profit Report & AI Based Buy/Sell Signal Reports - newser.com
How to integrate Exicure Inc. into portfolio analysis toolsMarket Risk Report & Weekly High Return Stock Opportunities - newser.com
Will Exicure Inc. stock continue upward momentumPortfolio Growth Summary & Expert Approved Momentum Ideas - newser.com
Why Exicure Inc. (2H0) stock appeals to dividend investorsJuly 2025 Analyst Calls & Daily Technical Forecast Reports - newser.com
Evaluating Exicure Inc. with trendline analysisBond Market & Capital Protection Trading Alerts - newser.com
What margin trends mean for Exicure Inc. stockEarnings Risk Summary & Free High Return Stock Watch Alerts - newser.com
Applying sector rotation models to Exicure Inc.Rate Hike & Fast Momentum Stock Entry Tips - newser.com
What technical models suggest about Exicure Inc.’s comebackJuly 2025 Movers & Safe Capital Investment Plans - newser.com
Building trade automation scripts for Exicure Inc.2025 Price Action Summary & Step-by-Step Swing Trade Plans - newser.com
Volume spikes in Exicure Inc. stock – what they meanJuly 2025 News Drivers & Expert-Curated Trade Recommendations - newser.com
Will Exicure Inc. stock outperform growth indexesJuly 2025 Market Mood & Precise Buy Zone Tips - newser.com
Exicure Inc Stock (XCUR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.14%
0.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):